Global CRO Chiltern has earned two Clinical Researcher of the Year (CRoY) winners in the U.K., joining the five finalists previously announced from the U.S. Sarah Jones earned the Gold Pharma in the CTA category and Helen Greenleaf earned Bronze as an Aspiring CRA. Both Chiltern Source professionals are working with Novartis.

"We are very pleased for Helen and Sarah to earn this recognition as top performers in the industry," said Nannette Penny, Chiltern's executive director for Chiltern Source in Europe. "They both have the skills and motivation to do great things in their clinical research careers, and have contributed significantly to Chiltern's strong partnership with Novartis."

Chiltern has been a premier sponsor for this year's Americas and International Clinical Researcher of the Year competition events.

Bill Donovan, Chiltern's chief source officer, said, "We're delighted with the recognition for Chiltern during this year's PharmaTimes CRoY competitions. Chiltern Source is working to develop and strengthen the people of our industry, and this competition represents the epitome of what we're striving to achieve for the clinical research talent pool. To have seven finalists globally, and now to host the competition also, is very exciting. I'm proud of our team and their efforts and we welcome the Americas finalists coming to Chiltern in June."

The PharmaTimes Clinical Researcher of the Year is a multi-stage competition designed to test the knowledge, competency and innovation toward finding the top performing clinical researchers globally. Finals are run separately for Americas and International, during which competitors complete a one-day case-based challenge presentation in front of a panel of judges. Finalists have been chosen by executive committees of industry experts from small and large biopharmaceutical companies, site management groups, CROs and other organizations involved in clinical research.